The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Immunodeficiency Virus Testing-Global Market Insights and Sales Trends 2025
Synopsis
Human Immunodeficiency Virus Testing is the procedure to test if the patient have the Human Immunodeficiency Virus
The global Human Immunodeficiency Virus Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Human Immunodeficiency Virus Testing in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Home Use,, are propelling Human Immunodeficiency Virus Testing market. Antibody Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA (viral load) Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Human Immunodeficiency Virus Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Human Immunodeficiency Virus Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Immunodeficiency Virus Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Immunodeficiency Virus Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Immunodeficiency Virus Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Immunodeficiency Virus Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Immunodeficiency Virus Testing covered in this report include Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon and Intec, etc.
The global Human Immunodeficiency Virus Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Bio-Rad
WanTai BioPharm
Beckman Coulter
BD
Kehua
Livzon
Intec
ThermoFisher
Biokit
Nectar Lifesciences
ELITech Group
Chembio Diagnostic Systems
Trinity Biotech
Global Human Immunodeficiency Virus Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Immunodeficiency Virus Testing market, Segment by Type:
Antibody Tests
RNA (viral load) Test
Antibody-antigen Test
Global Human Immunodeficiency Virus Testing market, by Application
Diagnostic Centers
Hospitals
Home Use
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Immunodeficiency Virus Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Human Immunodeficiency Virus Testing is the procedure to test if the patient have the Human Immunodeficiency Virus
The global Human Immunodeficiency Virus Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Human Immunodeficiency Virus Testing in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Home Use,, are propelling Human Immunodeficiency Virus Testing market. Antibody Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA (viral load) Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Human Immunodeficiency Virus Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Human Immunodeficiency Virus Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Immunodeficiency Virus Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Immunodeficiency Virus Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Immunodeficiency Virus Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Immunodeficiency Virus Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Immunodeficiency Virus Testing covered in this report include Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon and Intec, etc.
The global Human Immunodeficiency Virus Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Bio-Rad
WanTai BioPharm
Beckman Coulter
BD
Kehua
Livzon
Intec
ThermoFisher
Biokit
Nectar Lifesciences
ELITech Group
Chembio Diagnostic Systems
Trinity Biotech
Global Human Immunodeficiency Virus Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Immunodeficiency Virus Testing market, Segment by Type:
Antibody Tests
RNA (viral load) Test
Antibody-antigen Test
Global Human Immunodeficiency Virus Testing market, by Application
Diagnostic Centers
Hospitals
Home Use
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Immunodeficiency Virus Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Human Immunodeficiency Virus Testing
1.1 Human Immunodeficiency Virus Testing Market Overview
1.1.1 Human Immunodeficiency Virus Testing Product Scope
1.1.2 Human Immunodeficiency Virus Testing Market Status and Outlook
1.2 Global Human Immunodeficiency Virus Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Human Immunodeficiency Virus Testing Market Size by Region (2018-2029)
1.4 Global Human Immunodeficiency Virus Testing Historic Market Size by Region (2018-2023)
1.5 Global Human Immunodeficiency Virus Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Human Immunodeficiency Virus Testing Market Size (2018-2029)
1.6.1 North America Human Immunodeficiency Virus Testing Market Size (2018-2029)
1.6.2 Europe Human Immunodeficiency Virus Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Human Immunodeficiency Virus Testing Market Size (2018-2029)
1.6.4 Latin America Human Immunodeficiency Virus Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Human Immunodeficiency Virus Testing Market Size (2018-2029)
2 Human Immunodeficiency Virus Testing Market by Type
2.1 Introduction
2.1.1 Antibody Tests
2.1.2 RNA (viral load) Test
2.1.3 Antibody-antigen Test
2.2 Global Human Immunodeficiency Virus Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Human Immunodeficiency Virus Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Human Immunodeficiency Virus Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Human Immunodeficiency Virus Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Human Immunodeficiency Virus Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Human Immunodeficiency Virus Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Human Immunodeficiency Virus Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Human Immunodeficiency Virus Testing Revenue Breakdown by Type (2018-2029)
3 Human Immunodeficiency Virus Testing Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Centers
3.1.2 Hospitals
3.1.3 Home Use
3.2 Global Human Immunodeficiency Virus Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Human Immunodeficiency Virus Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Human Immunodeficiency Virus Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Human Immunodeficiency Virus Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Human Immunodeficiency Virus Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Human Immunodeficiency Virus Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Human Immunodeficiency Virus Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Human Immunodeficiency Virus Testing Revenue Breakdown by Application (2018-2029)
4 Human Immunodeficiency Virus Testing Competition Analysis by Players
4.1 Global Human Immunodeficiency Virus Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus Testing as of 2022)
4.3 Date of Key Players Enter into Human Immunodeficiency Virus Testing Market
4.4 Global Top Players Human Immunodeficiency Virus Testing Headquarters and Area Served
4.5 Key Players Human Immunodeficiency Virus Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Human Immunodeficiency Virus Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Human Immunodeficiency Virus Testing Products, Services and Solutions
5.1.4 Roche Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Human Immunodeficiency Virus Testing Products, Services and Solutions
5.2.4 Abbott Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Bio-Rad
5.3.1 Bio-Rad Profile
5.3.2 Bio-Rad Main Business
5.3.3 Bio-Rad Human Immunodeficiency Virus Testing Products, Services and Solutions
5.3.4 Bio-Rad Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.3.5 WanTai BioPharm Recent Developments
5.4 WanTai BioPharm
5.4.1 WanTai BioPharm Profile
5.4.2 WanTai BioPharm Main Business
5.4.3 WanTai BioPharm Human Immunodeficiency Virus Testing Products, Services and Solutions
5.4.4 WanTai BioPharm Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.4.5 WanTai BioPharm Recent Developments
5.5 Beckman Coulter
5.5.1 Beckman Coulter Profile
5.5.2 Beckman Coulter Main Business
5.5.3 Beckman Coulter Human Immunodeficiency Virus Testing Products, Services and Solutions
5.5.4 Beckman Coulter Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Human Immunodeficiency Virus Testing Products, Services and Solutions
5.6.4 BD Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 Kehua
5.7.1 Kehua Profile
5.7.2 Kehua Main Business
5.7.3 Kehua Human Immunodeficiency Virus Testing Products, Services and Solutions
5.7.4 Kehua Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Kehua Recent Developments
5.8 Livzon
5.8.1 Livzon Profile
5.8.2 Livzon Main Business
5.8.3 Livzon Human Immunodeficiency Virus Testing Products, Services and Solutions
5.8.4 Livzon Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Livzon Recent Developments
5.9 Intec
5.9.1 Intec Profile
5.9.2 Intec Main Business
5.9.3 Intec Human Immunodeficiency Virus Testing Products, Services and Solutions
5.9.4 Intec Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Intec Recent Developments
5.10 ThermoFisher
5.10.1 ThermoFisher Profile
5.10.2 ThermoFisher Main Business
5.10.3 ThermoFisher Human Immunodeficiency Virus Testing Products, Services and Solutions
5.10.4 ThermoFisher Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.10.5 ThermoFisher Recent Developments
5.11 Biokit
5.11.1 Biokit Profile
5.11.2 Biokit Main Business
5.11.3 Biokit Human Immunodeficiency Virus Testing Products, Services and Solutions
5.11.4 Biokit Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Biokit Recent Developments
5.12 Nectar Lifesciences
5.12.1 Nectar Lifesciences Profile
5.12.2 Nectar Lifesciences Main Business
5.12.3 Nectar Lifesciences Human Immunodeficiency Virus Testing Products, Services and Solutions
5.12.4 Nectar Lifesciences Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Nectar Lifesciences Recent Developments
5.13 ELITech Group
5.13.1 ELITech Group Profile
5.13.2 ELITech Group Main Business
5.13.3 ELITech Group Human Immunodeficiency Virus Testing Products, Services and Solutions
5.13.4 ELITech Group Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.13.5 ELITech Group Recent Developments
5.14 Chembio Diagnostic Systems
5.14.1 Chembio Diagnostic Systems Profile
5.14.2 Chembio Diagnostic Systems Main Business
5.14.3 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Products, Services and Solutions
5.14.4 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Chembio Diagnostic Systems Recent Developments
5.15 Trinity Biotech
5.15.1 Trinity Biotech Profile
5.15.2 Trinity Biotech Main Business
5.15.3 Trinity Biotech Human Immunodeficiency Virus Testing Products, Services and Solutions
5.15.4 Trinity Biotech Human Immunodeficiency Virus Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Trinity Biotech Recent Developments
6 North America
6.1 North America Human Immunodeficiency Virus Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human Immunodeficiency Virus Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human Immunodeficiency Virus Testing Market Dynamics
11.1 Human Immunodeficiency Virus Testing Industry Trends
11.2 Human Immunodeficiency Virus Testing Market Drivers
11.3 Human Immunodeficiency Virus Testing Market Challenges
11.4 Human Immunodeficiency Virus Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
